Diagnosis and treatment of CD20 negative B cell lymphomas

CD20 negative B cell non-Hodgkin lymphoma (NHL) is rare and accounts for approximately 1-2% of B cell lymphomas. CD20- negative NHL is frequently associated with extranodal involvement, atypical morphology, aggressive clinical behaviour, resistance to standard chemotherapy and poor prognosis. The mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Katchi, Tasleem, Liu, Delong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297138/
https://www.ncbi.nlm.nih.gov/pubmed/28191314
http://dx.doi.org/10.1186/s40364-017-0088-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297138/
https://www.ncbi.nlm.nih.gov/pubmed/28191314
http://dx.doi.org/10.1186/s40364-017-0088-5

Ejemplares similares